Completed Cells, Biochemistry & Physiology Brain & Nervous System

The mechanisms of photoreceptor cell death

In plain English

AI plain-English summary

A single faulty protein inside the eye’s light-sensitive cells can trigger a chain reaction that kills them, leading to a form of inherited blindness called retinitis pigmentosa. This matters because rhodopsin mutations are the most common cause of dominant retinitis pigmentosa in the UK, yet no one knows exactly how they disrupt the cell’s protein quality-control systems—or how to stop them. The researcher will use gene editing and stem-cell technology to build new animal and patient-derived models of the key rhodopsin mutations, then systematically test which stress and degradation pathways go wrong. By identifying the proteins that partner with mutant rhodopsin, the work aims to reveal common disease mechanisms across different mutation classes. If successful, the findings could point toward new therapies for rhodopsin-driven retinal degeneration. Because the underlying problem—failed protein homeostasis—also occurs in other neurodegenerative diseases such as Alzheimer’s and Parkinson’s, the insights may extend well beyond the eye. This is fundamental science: it asks how a single mutation derails a cell’s internal housekeeping, a question whose answers could eventually reshape how we think about protein-misfolding diseases.

View original technical description
Problems of protein homeostasis (proteostasis) that lead to protein misfolding, improper traffic and aggregation are associated with many forms of neurodegeneration. The neurodegeneration retinitis pigmentosa (RP) offers an excellent paradigm to study why proteostasis is critical for neuronal function and survival. Rhodopsin mutations cause dominant RP and disturb proteostasis, yet the underlying disease mechanisms and effective therapies remain elusive. I will exploit recent advances in gene editing technology and stem cell biology to produce new animal and patient derived models of the most common rhodopsin mutations in the UK. I will use these to address my key goals, i) to define any common disease mechanisms between the different classes of mutation, and ii) identify new therapeutic approaches for rhodopsin RP. I will use a combination of genetic and chemical manipulation of the major cell stress and degradation pathways, and identify the partner proteins of rhodopsin mutants using unbiased proteomic analyses. These complementary studies will be based on a series of interlinked hypotheses to determine how rhodopsin mutations disturb protein homeostasis and if this can be restored. The findings will have broader implications not only for other forms of retinal degeneration, but also neurodegenerative disease where proteostasis is disturbed.

View the original record at the funder ↗

Researchers

Michael Cheetham (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Defining the mechanism of photoreceptor cell death in Retinitis Pigmentosa
Modelling retinitis pigmentosa associated cone photoreceptor death using stem cell derived organoids
Understanding how lysosomes become dysfunctional in neurodegeneration
Clinical PhD Programme at the University of Edinburgh: "Rhodopsin trafficking defects in Retinitis Pigmentosa".
DRAM2: on the crossroad between trans-Golgi network and lysosomes?

Original classification

Investigator Award in Science

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.